Literature DB >> 19249797

Cerebral emboli in the genesis of dementia.

Nitin Purandare1, Alistair Burns.   

Abstract

Alzheimer's disease (AD) and vascular dementia (VaD) are the two commonest forms of dementia, with evidence of a considerable overlap between them. Vascular risk factors are important in the genesis of both dementias but underlying mechanisms need further exploration. In this respect, asymptomatic spontaneous cerebral emboli (SCE) may be of interest. Such emboli are common in patients at risk of stroke, for example those with symptomatic or severe carotid artery disease, and predict the future risk of strokes. Here we summarise our research which shows that asymptomatic SCE may be involved in the aetiology, symptomatology and progression of both AD and VaD. In just 1 h of transcranial Doppler (TCD) monitoring SCE were detected in 40% of AD and 37% of VaD patients compared to 15% and 14% of their respective controls. The odds ratio for SCE was 2.70 (1.18-6.21) for AD and 5.36 (1.24-23.18) for VaD, adjusted for cardiovascular risk factors. The presence of SCE was associated with the concurrent presence of clinically relevant depressive symptoms and the future rapid rates of decline in cognition and daily function. SCE may represent a potentially treatable target to slow and possibly prevent dementia, both AD and VaD.

Entities:  

Mesh:

Year:  2009        PMID: 19249797     DOI: 10.1016/j.jns.2009.02.306

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability.

Authors:  Georgette L Suidan; Pradeep K Singh; Sunita Patel-Hett; Zu-Lin Chen; Dmitri Volfson; Hitomi Yamamoto-Imoto; Erin H Norris; Robert D Bell; Sidney Strickland
Journal:  Blood Adv       Date:  2018-05-08

2.  Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia.

Authors:  M A Koike; F G Garcia; M Kitazawa; K N Green; F M Laferla
Journal:  Neurosci Lett       Date:  2011-03-23       Impact factor: 3.046

3.  Amyloid-β Causes Mitochondrial Dysfunction via a Ca2+-Driven Upregulation of Oxidative Phosphorylation and Superoxide Production in Cerebrovascular Endothelial Cells.

Authors:  Dominic D Quintana; Jorge A Garcia; Yamini Anantula; Stephanie L Rellick; Elizabeth B Engler-Chiurazzi; Saumyendra N Sarkar; Candice M Brown; James W Simpkins
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Justin Paul; Erin H Norris; Robert Bronstein; Hyung Jin Ahn; Daria Zamolodchikov; Shivaprasad Bhuvanendran; Katherine M Fenz; Sidney Strickland
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

5.  Carotid atherosclerotic plaque instability and cognition determined by ultrasound-measured plaque strain in asymptomatic patients with significant stenosis.

Authors:  Robert J Dempsey; Tomy Varghese; Daren C Jackson; Xiao Wang; Nirvedh H Meshram; Carol C Mitchell; Bruce P Hermann; Sterling C Johnson; Sara E Berman; Stephanie M Wilbrand
Journal:  J Neurosurg       Date:  2017-03-10       Impact factor: 5.115

6.  The Preservation of Cognition 1 Year After Carotid Endarterectomy in Patients With Prior Cognitive Decline.

Authors:  Robert J Dempsey; Daren C Jackson; Stephanie M Wilbrand; Carol C Mitchell; Sara E Berman; Sterling C Johnson; Nirvedh H Meshram; Tomy Varghese; Bruce P Hermann
Journal:  Neurosurgery       Date:  2018-03-01       Impact factor: 4.654

7.  Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.

Authors:  Y C Chung; A Kruyer; Y Yao; E Feierman; A Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2016-06-13       Impact factor: 5.824

Review 8.  Fibrinogen and altered hemostasis in Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Daria Zamolodchikov; Hyung Jin Ahn; Sidney Strickland; Erin H Norris
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Cerebrovascular function in aging and dementia: a systematic review of transcranial Doppler studies.

Authors:  Hannah A D Keage; Owen F Churches; Mark Kohler; Danielle Pomeroy; Rocco Luppino; Michelle L Bartolo; Scott Elliott
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-06-29

Review 10.  Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease.

Authors:  Ilaria Canobbio; Aisha Alsheikh Abubaker; Caterina Visconte; Mauro Torti; Giordano Pula
Journal:  Front Cell Neurosci       Date:  2015-03-03       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.